162 related articles for article (PubMed ID: 14530907)
1. Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins.
Fehrenbach T; Cui Y; Faulstich H; Keppler D
Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov; 368(5):415-20. PubMed ID: 14530907
[TBL] [Abstract][Full Text] [Related]
2. Influence of albumin binding on the substrate transport mediated by human hepatocyte transporters OATP2 and OATP8.
Cui Y; Walter B
J Gastroenterol; 2003; 38(1):60-8. PubMed ID: 12560923
[TBL] [Abstract][Full Text] [Related]
3. Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
Vavricka SR; Van Montfoort J; Ha HR; Meier PJ; Fattinger K
Hepatology; 2002 Jul; 36(1):164-72. PubMed ID: 12085361
[TBL] [Abstract][Full Text] [Related]
4. Detection of the human organic anion transporters SLC21A6 (OATP2) and SLC21A8 (OATP8) in liver and hepatocellular carcinoma.
Cui Y; König J; Nies AT; Pfannschmidt M; Hergt M; Franke WW; Alt W; Moll R; Keppler D
Lab Invest; 2003 Apr; 83(4):527-38. PubMed ID: 12695556
[TBL] [Abstract][Full Text] [Related]
5. Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport.
Kindla J; Müller F; Mieth M; Fromm MF; König J
Drug Metab Dispos; 2011 Jun; 39(6):1047-53. PubMed ID: 21389119
[TBL] [Abstract][Full Text] [Related]
6. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
Noé J; Portmann R; Brun ME; Funk C
Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528
[TBL] [Abstract][Full Text] [Related]
7. Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3.
Gozalpour E; Greupink R; Wortelboer HM; Bilos A; Schreurs M; Russel FG; Koenderink JB
Mol Pharm; 2014 Jun; 11(6):1844-55. PubMed ID: 24754247
[TBL] [Abstract][Full Text] [Related]
8. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6.
Cui Y; König J; Leier I; Buchholz U; Keppler D
J Biol Chem; 2001 Mar; 276(13):9626-30. PubMed ID: 11134001
[TBL] [Abstract][Full Text] [Related]
9. Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans.
Hirano M; Maeda K; Shitara Y; Sugiyama Y
J Pharmacol Exp Ther; 2004 Oct; 311(1):139-46. PubMed ID: 15159445
[TBL] [Abstract][Full Text] [Related]
10. Identification of phalloidin uptake systems of rat and human liver.
Meier-Abt F; Faulstich H; Hagenbuch B
Biochim Biophys Acta; 2004 Jul; 1664(1):64-9. PubMed ID: 15238259
[TBL] [Abstract][Full Text] [Related]
11. In vitro inhibition of OATP-mediated uptake of phalloidin using bile acid derivatives.
Herraez E; Macias RI; Vazquez-Tato J; Vicens M; Monte MJ; Marin JJ
Toxicol Appl Pharmacol; 2009 Aug; 239(1):13-20. PubMed ID: 19464309
[TBL] [Abstract][Full Text] [Related]
12. Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity data.
Kunze A; Huwyler J; Camenisch G; Poller B
Drug Metab Dispos; 2014 Sep; 42(9):1514-21. PubMed ID: 24989890
[TBL] [Abstract][Full Text] [Related]
13. The organic anion transport polypeptide 1d1 (Oatp1d1) mediates hepatocellular uptake of phalloidin and microcystin into skate liver.
Meier-Abt F; Hammann-Hänni A; Stieger B; Ballatori N; Boyer JL
Toxicol Appl Pharmacol; 2007 Feb; 218(3):274-9. PubMed ID: 17198718
[TBL] [Abstract][Full Text] [Related]
14. Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1.
Bachmakov I; Glaeser H; Fromm MF; König J
Diabetes; 2008 Jun; 57(6):1463-9. PubMed ID: 18314419
[TBL] [Abstract][Full Text] [Related]
15. Expression and transport function of drug uptake transporters in differentiated HepaRG cells.
Kotani N; Maeda K; Debori Y; Camus S; Li R; Chesne C; Sugiyama Y
Mol Pharm; 2012 Dec; 9(12):3434-41. PubMed ID: 22897388
[TBL] [Abstract][Full Text] [Related]
16. Contribution of OATP (organic anion-transporting polypeptide) family transporters to the hepatic uptake of fexofenadine in humans.
Shimizu M; Fuse K; Okudaira K; Nishigaki R; Maeda K; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2005 Oct; 33(10):1477-81. PubMed ID: 16014768
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatic uptake transporters by flavonoids.
Mandery K; Balk B; Bujok K; Schmidt I; Fromm MF; Glaeser H
Eur J Pharm Sci; 2012 May; 46(1-2):79-85. PubMed ID: 22394605
[TBL] [Abstract][Full Text] [Related]
18. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide.
König J; Cui Y; Nies AT; Keppler D
J Biol Chem; 2000 Jul; 275(30):23161-8. PubMed ID: 10779507
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a set of double transfectants coexpressing organic anion transporting polypeptide 1B3 and hepatic efflux transporters for the characterization of the hepatobiliary transport of telmisartan acylglucuronide.
Ishiguro N; Maeda K; Saito A; Kishimoto W; Matsushima S; Ebner T; Roth W; Igarashi T; Sugiyama Y
Drug Metab Dispos; 2008 Apr; 36(4):796-805. PubMed ID: 18180273
[TBL] [Abstract][Full Text] [Related]
20. The influence of oral antidiabetic drugs on cellular drug uptake mediated by hepatic OATP family members.
Klatt S; Fromm MF; König J
Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):244-50. PubMed ID: 23121773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
